Medpace (MEDP) closed at $616.45 in the latest trading session, marking a +1.32% move from the prior day. The stock's performance was ahead of the S&P 500's daily loss of 0.53%. Meanwhile, the Dow lost 0.09%, and the Nasdaq, a tech-heavy index, lost 1%. The stock of provider of outsourced clinical development services has risen by 8.89% in the past month, leading the Medical sector's gain of 0.09% and the S&P 500's gain of 2.06%.Investors will be eagerly watching for the performance of Medpace in its upcomi ...